-
-
-
-
-
-
-
Qiagen guides to at least 5% sales growth in 2026
-
-
-
-
-
-
-
QIAGEN beats Q3 outlook, raises EPS target and announces $500M buyback
-
-
-
-
-
-
-
QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds
-
-
-
-
-
-
-
QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.
-
-
-
-
-
-
-
QIAGEN announces new Chairman of Supervisory Board
-
-
-
-
-
-
-
QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo Fisher
-
-
-
-
-
-
-
QIAGEN Announces Publication of Reasoned Position Statement for Proposed Acquisition by Thermo Fisher and Date for Annual General Meeting
-
1,206,169 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


